Clinical Trials
2 trialsNCT05237947 2026-05-28
PRISMA
National Cancer Institute (NCI)
Phase 4 Active not recruiting
NCT06639074 2025-10-02
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial
Mayo Clinic
Phase 2 Recruiting